Affordable Access

Counterfeit drugs: defining the problem and finding solutions.

Authors
  • Wertheimer, Albert I
  • Santella, Thomas M
Type
Published Article
Journal
Expert Opinion on Drug Safety
Publisher
Informa UK (Taylor & Francis)
Publication Date
Jul 01, 2005
Volume
4
Issue
4
Pages
619–622
Identifiers
PMID: 16011440
Source
Medline
License
Unknown

Abstract

The problem of counterfeit drugs is increasingly becoming a top priority of drug regulatory agencies, licit pharmaceutical manufacturers and healthcare professionals, and is of rising concern among consumers. A review of the current literature reveals that counterfeiting is no longer isolated in developing nations, but is a worldwide pandemic. Although international organisations such as the World Health Organization, have devised specific measures to combat the counterfeit trade, the problem still remains quite daunting. Although the practice of drug counterfeiting is unlikely to ever completely disappear, it may be controlled if governments and all relevant parties combine forces to identify and disrupt the counterfeit chain.

Report this publication

Statistics

Seen <100 times